Loading…
Back To Schedule
Monday, September 19 • 2:00pm - 2:45pm
Panel: Perfect the Handoff from Clinical to Commercial

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
  • Identify the best ways to strengthen collaboration between the different internal teams as the asset is handed off to the commercial, marketing and branding group
  • Describe how improved cooperation can impact strategic product development
Speakers
avatar for Tom Gilbert Jr, MS, MBA

Tom Gilbert Jr, MS, MBA

Executive Director, New Product and Launch Planning, Seres Therapeutics
Tom has over 20 years of experience leading cross-functional teams in developing and executing US and Global commercial strategy for both pipeline and in-line compounds across neuroscience and gastroenterology disease areas. Over the course of his career, Tom has served as the commercial... Read More →
avatar for Jaya Subramaniam

Jaya Subramaniam

Chief Strategy Officer, Analytical Wizards, a Definitive Healthcare Company
Jaya Subramaniam is the Chief Strategy Officer at Analytical Wizards, a Definitive Healthcare Company, and served on the Board of Directors of Analytical Wizards. She currently serves on the Executive Leadership Team of Definitive Healthcare.Jaya has over 20+ years in the pharma industry... Read More →
avatar for Everett Crosland JD, MSc

Everett Crosland JD, MSc

Chief Commercial Officer, Cognito Therapeutics, Inc.
Everett leads the commercial organization at Cognito Therapeutics, a pioneer in non-invasive optogenetics to treat neurodegenerative diseases and improve human cognitive performance. Cognito has received FDA Breakthrough Device Designation for the treatment of Alzheimer’s disease... Read More →
avatar for Kelli Tea, MBA

Kelli Tea, MBA

Head of Commercial and Corporate Development, Protara Therapeutics
Protara Therapeutics is a NYC headquartered clinical-stage biotech company committed to identifying and advancing transformative therapies for people with cancer and rare diseases with limited treatment options. Kelli is responsible for heading up Commercial and Corporate Development... Read More →

Monday September 19, 2022 2:00pm - 2:45pm EDT
  General Session